15 results
8-K
EX-10.1
CGTX
Cognition Therapeutics Inc
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
, will be made available by the Company for examination and packaging by the Agents in The City of New York not later than noon (New York time) on the Business
S-3
EX-1.2
CGTX
Cognition Therapeutics Inc
23 Dec 22
Shelf registration
4:16pm
, will be made available by the Company for examination and packaging by the Agents in The City of New York not later than noon (New York time) on the Business
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
.
If our product candidates are approved, they will be subject to ongoing regulatory requirements for manufacturing, labeling, packaging, storage … .
CT1812 drug product is manufactured via conventional pharmaceutical processing procedures, employing commercially available excipients and packaging
DRS
2o2x swgsiqi2uy1mab
20 Oct 22
Draft registration statement
12:00am
10-K
sj9f9wpb12de0sj4164c
30 Mar 22
Annual report
7:40am
10-Q
gdgsdc10qqt10 tkbbo
17 Nov 21
Quarterly report
5:15pm
424B4
dk88 8639qcl
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
ptg24
19 Jul 21
IPO registration
7:02am
DRS/A
lxilgn pxav9hei
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
10lv0wibas 7pg7
7 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next